• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

哮喘新疗法。

New Treatments for Asthma.

机构信息

Division of Allergy and Immunology, Department of Pediatrics,Children's Hospital of Michigan, Suite #4022, 4th Floor, 3950 Beaubien Boulevard, Detroit, MI 48201, USA.

Division of Allergy and Immunology, Department of Pediatrics, Children's Hospital of Michigan, Pediatric Specialty Center, Wayne State University, Suite # 4018, 4th Floor, 3950 Beaubien Boulevard, Detroit, MI 48201, USA.

出版信息

Pediatr Clin North Am. 2019 Oct;66(5):925-939. doi: 10.1016/j.pcl.2019.06.001.

DOI:10.1016/j.pcl.2019.06.001
PMID:31466682
Abstract

Asthma is a complex, heterogeneous chronic airway disease with high prevalence of uncontrolled disease. New therapies, including biologics, are now available to treat T2 high asthma. Treatment of T2 low asthma remains a challenge. Asthma guidelines need be to updated to incorporate new therapeutics.

摘要

哮喘是一种复杂、异质性的慢性气道疾病,其疾病未得到控制的情况较为普遍。目前已有新型疗法,包括生物制剂,可用于治疗 T2 高型哮喘。T2 低型哮喘的治疗仍然是一个挑战。哮喘指南需要更新,以纳入新的治疗方法。

相似文献

1
New Treatments for Asthma.哮喘新疗法。
Pediatr Clin North Am. 2019 Oct;66(5):925-939. doi: 10.1016/j.pcl.2019.06.001.
2
New Treatments for Asthma.哮喘新疗法。
Immunol Allergy Clin North Am. 2021 Nov;41(4):555-569. doi: 10.1016/j.iac.2021.07.013.
3
Guiding principles for use of newer biologics and bronchial thermoplasty for patients with severe asthma.重度哮喘患者使用新型生物制剂和支气管热成形术的指导原则。
Ann Allergy Asthma Immunol. 2017 Dec;119(6):533-540. doi: 10.1016/j.anai.2017.09.058. Epub 2017 Nov 2.
4
Bronchial thermoplasty and biological therapy as targeted treatments for severe uncontrolled asthma.支气管热成形术和生物疗法作为严重难治性哮喘的靶向治疗。
Lancet Respir Med. 2016 Jul;4(7):585-592. doi: 10.1016/S2213-2600(16)30018-2. Epub 2016 May 24.
5
Recent Advances in Severe Asthma: From Phenotypes to Personalized Medicine.严重哮喘的最新进展:从表型到个体化医学。
Chest. 2020 Mar;157(3):516-528. doi: 10.1016/j.chest.2019.10.009. Epub 2019 Oct 31.
6
Molecular Targets for Biological Therapies of Severe Asthma.重度哮喘的生物治疗的分子靶点。
Front Immunol. 2020 Nov 30;11:603312. doi: 10.3389/fimmu.2020.603312. eCollection 2020.
7
Asthma in 2016: reassured about the old, excited about the new.2016年的哮喘:对旧有情况放心,对新情况激动。
Lancet Respir Med. 2016 Dec;4(12):937-939. doi: 10.1016/S2213-2600(16)30380-0. Epub 2016 Nov 22.
8
Biologics and Bronchial Thermoplasty for severe refractory asthma treatment: From eligibility criteria to real practice. A cross-sectional study.生物制剂和支气管热成形术治疗严重难治性哮喘:从入选标准到实际应用。一项横断面研究。
Pulm Pharmacol Ther. 2020 Feb;60:101874. doi: 10.1016/j.pupt.2019.101874. Epub 2019 Dec 16.
9
[Update in severe asthma physiopathology and treatments].[重度哮喘的病理生理学与治疗进展]
Rev Med Interne. 2019 Aug;40(8):508-516. doi: 10.1016/j.revmed.2019.04.007. Epub 2019 May 22.
10
The clinical profile of benralizumab in the management of severe eosinophilic asthma.贝那利珠单抗治疗重度嗜酸性粒细胞性哮喘的临床概况。
Ther Adv Respir Dis. 2016 Dec;10(6):534-548. doi: 10.1177/1753465816667659. Epub 2016 Sep 9.

引用本文的文献

1
Biologic Therapy in Severe Asthma: A Phenotype-Driven and Targeted Approach.重度哮喘的生物治疗:一种基于表型驱动的靶向治疗方法。
J Clin Med. 2025 Jul 4;14(13):4749. doi: 10.3390/jcm14134749.
2
The association of polyunsaturated fatty acids and asthma: a cross-sectional study.多不饱和脂肪酸与哮喘的关联:一项横断面研究。
J Health Popul Nutr. 2023 Sep 1;42(1):91. doi: 10.1186/s41043-023-00435-w.
3
The Effects of a Transgelin-2 Agonist Administered at Different Times in a Mouse Model of Airway Hyperresponsiveness.在气道高反应性小鼠模型中不同时间给予转胶蛋白-2激动剂的效果
Front Pharmacol. 2022 Jun 16;13:873612. doi: 10.3389/fphar.2022.873612. eCollection 2022.
4
Impact of Therapeutics on Unified Immunity During Allergic Asthma and Respiratory Infections.治疗方法对过敏性哮喘和呼吸道感染期间整体免疫的影响。
Front Allergy. 2022 Mar 25;3:852067. doi: 10.3389/falgy.2022.852067. eCollection 2022.
5
YG-1 Extract Improves Acute Pulmonary Inflammation by Inducing Bronchodilation and Inhibiting Inflammatory Cytokines.YG-1 提取物通过诱导支气管扩张和抑制炎症细胞因子来改善急性肺部炎症。
Nutrients. 2021 Sep 28;13(10):3414. doi: 10.3390/nu13103414.
6
Syndecan-1 Amplifies Ovalbumin-Induced Airway Remodeling by Strengthening TGFβ1/Smad3 Action.Syndecan-1 通过增强 TGFβ1/Smad3 作用放大卵清蛋白诱导的气道重塑。
Front Immunol. 2021 Oct 4;12:744477. doi: 10.3389/fimmu.2021.744477. eCollection 2021.
7
Biological therapy for severe asthma.重度哮喘的生物治疗
Asthma Res Pract. 2021 Aug 13;7(1):12. doi: 10.1186/s40733-021-00078-w.